Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 3Solid Carcinoma 2Diarrhea 2Vomiting 1Pancreatic Neoplasms 1Nausea 1Melanoma 1Kidney Neoplasms 1Constipation 1Colitis 1Advanced Gastric Cancer 1Adenocarcinoma Of Esophagus 1

Interventions

Endoscopy, Digestive System 3Endoscopy 3Radiotherapy 2Biopsy 2chlorhexidine gluconate 1Specimen Handling 1Risk Assessment 1Radiation 1Nivolumab 1Mass Screening 1Magnetic Resonance Spectroscopy 1Immune Checkpoint Inhibitors 1High-Throughput Screening Assays 1High-Intensity Interval Training 1Hematologic Tests 1Gene Expression Profiling 1Fluorodeoxyglucose F18 1Fecal Microbiota Transplantation 1Endoscopic Ultrasound-Guided Fine Needle Aspiration 1Endoscopic Mucosal Resection 1Drug Therapy 1Cryotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Adenocarcinoma Of Esophagus × Fecal Microbiota Transplantation × Clear all
NCT05001360 2021-10-27

Study of FMT Combined With Nivolumab in Gastric Cancer

Fujian Cancer Hospital

Phase NA Withdrawn
Gastrointestinal

Adenocarcinoma Of Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡